Dss, Inc.

Dss, Inc. is listed in filings as 10% Owner at Impact BioMedical Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including sale activity and purchase activity. Recent filings connect the profile to Impact BioMedical Inc. (IBO). The current snapshot covers public activity from Sep 18, 2024 to Jan 6, 2026. Reported amounts are shown as $24.5K to $845.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.